Chemomab Therapeutics Ltd.
CMMB
Revenue
0.00
0.000.00%
-Assets
12.57M
▲10.49M▲502.49%
12 Months ChangeLiabilities
13.66M
▲10.97M▲406.82%
12 Months ChangeFree Cash Flow
-7.19M
▼-3.46M▼-92.94%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-06-16
Form 8-K
ID: 0001178913-23-002225
2023-06-05
Form 8-K
ID: 0001178913-23-002136
2023-05-11
Form 8-K
ID: 0001178913-23-001809
2023-05-11
Form 10-Q
ID: 0001178913-23-001807
2023-02-21
Form 8-K
ID: 0001178913-23-000679
2023-02-21
Form 8-K
ID: 0001178913-23-000670
2023-01-11
Form 8-K
ID: 0001178913-23-000147
2023-01-03
Form 8-K
ID: 0001178913-23-000010
2022-11-16
Form 8-K
ID: 0001178913-22-004061
2022-11-14
Form 8-K
ID: 0001178913-22-004019